Core Products

All Products

The following information is for healthcare professionals only.

Oncology Central Nervous System Metabolism Cardiovascular Others

Global Market

Focused on the central nervous system, oncology, cardiovascular and other therapeutic areas,
with key products holding a leading position in their respective market segments.

International Market
Marketing network covers over 80 countries and regions including large global pharmaceutical markets and fast growing emerging markets. In-house sales teams have been established in Germany, the UK, Southeast Asia, the Middle East and North Africa.
Chinese Market
A commercial operation centered at the Group level, with products covering more than 21,000 hospitals across 31 provinces, municipalities and autonomous regions in China. From among these, oncology products are sold to approximately3,000 hospitals and CNS products sold to 3,000 hospitals

Focused on the central nervous system, oncology, cardiovascular and other therapeutic areas, with key products holding a leading position in their respective market segments

International Market
Marketing network covers over 80 countries and regions including large global pharmaceutical markets and fast growing emerging markets. In-house sales teams have been established in Germany, the UK, Southeast Asia, the Middle East and North Africa.
Chinese Market
A commercial operation centered at the Group level, with products covering more than 21,000 hospitals across 31 provinces, municipalities and autonomous regions in China. From among these, oncology products are sold to approximately3,000 hospitals and CNS products sold to 3,000 hospitals
 

Manufacturing Sites

Building a global supply chain with 8 manufacturing sites

ICH standards are followed from product design to construction of facilities

Manufacturing sites in China's Yantai, Nanjing, Beijing, Luzhou, and Chengdu are in compliance with international standards

The manufacturing site in Germany is one of the largest independent transdermal drug delivery systems production sites in Europe, boasting a highly sophisticated process and high barrier technologies

Building a global supply chain with 8 manufacturing sites and 30+ production lines worldwide

ICH standards are followed from product design to construction of facilities

The manufacturing sites in China's Yantai, Nanjing, Beijing, Luzhou and Chengdu are in compliance with international standards

The manufacturing site in Germany is one of the largest independent transdermal drug delivery systems production sites in Europe, boasting a highly sophisticated process and high barrier technologies

 

Quality Management

CHINA

  • Passed FDA cGMP inspection
  • Passed EU GMP inspections
  • Passed Australian TGA GMP inspections
  • Passed China 2010 GMP inspections
  • Obtained ISO9001:2015 QMS certification
  • Obtained CNAS certification

EUROPE

  • One of the largest independent TDS manufacturers in Europe, boasting highly sophisticated process and high barrier technologies
  • Passed FDA cGMP inspections
  • Passed EU GMP inspections
  • Passed Japanese GMP inspections
  • Passed Brazilian ANVISA inspections
  • Passed Columbian INVIMA inspections

CHINA

  • Passed FDA cGMP inspection
  • Passed EU GMP inspections
  • Passed Australian TGA GMP inspections
  • Passed China 2010 GMP inspections
  • Obtained ISO9001:2015 QMS certification
  • Obtained CNAS certification

EUROPE

  • One of the largest independent TDS manufacturers in Europe, boasting highly sophisticated process and high barrier technologies
  • Passed FDA cGMP inspections
  • Passed EU GMP inspections
  • Passed Japanese GMP inspections
  • Passed Brazilian ANVISA inspections
  • Passed Columbian INVIMA inspections
Adverse-Event